Food Recall Check
Class II · Moderate risk Ongoing Initiated Apr 17, 2024 (2 years ago)

Java Wafer Mocha Hazelnut recall

Recalled by Sacramento Cookie Factory · Sacramento, CA, United States

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Undeclared allergen (milk)

Undeclared allergen: Milk

For someone with a food allergy the label is the only protection. An undeclared allergen can trigger a severe reaction even in a trace amount, which is why most of these recalls are Class I. All undeclared allergens recalls.

What was recalled

Java Wafer - Mocha Hazelnut [Two sizes: retail package of 8 wafers (7 oz) and retail gift package of 2 wafers (2 oz)]

Quantity: Retail package of 8 wafers: 289 units; Retail Gift of 2 wafers: 150 units

Lot codes, dates and UPCs

A recall covers only these codes. Compare them with the lot number, best-by date or UPC printed on your package.

All best by dates up to 4/2/2025 (shelf life is 1 year from manufacture date). Firm does not apply lot codes.

Where it was sold

Alaska Alabama Arizona California Florida Georgia Iowa North Carolina New Jersey New York Tennessee Texas Virginia Washington

FDA's distribution note: U.S. Distribution to the following states: CA, AK, IA, NY, TX, FL, WA, NJ, WA, VA, GA, TN, AZ, AL, NC. For foreign or government distribution.

Check the codes, then return or discard. Class II means eating it may cause temporary or reversible health problems. If your package matches the recalled codes, do not eat it - return it to the store or throw it away. The risk from an undeclared allergen is to people allergic to milk; for anyone else the product is generally not a safety concern.

Recalling firm
Sacramento Cookie Factory
Initiated by
Voluntary: Firm initiated
Recall initiated
Apr 17, 2024
In FDA report of
May 15, 2024
FDA recall number
F-1215-2024 · event 94390
Official record
FDA enforcement report search

Also recalled with it (4 more products)

FDA files each product of one recall action separately; these share the same FDA event.